TNF-alpha drugs for Ulcerative Colitis

20 tracked TNF-alpha drugs in the Ulcerative Colitis race. The class explanation lives on the TNF-alpha page; the full indication pipeline across every mechanism is on the Ulcerative Colitis page.

18 approved / phase 41 Phase 31 Phase 1

Head-to-head evidence: JNJ-78934804 vs SOR102 · adalimumab vs JNJ-78934804 · golimumab vs JNJ-78934804 · infliximab vs JNJ-78934804 · infliximab-dyyb (Zymfentra) vs JNJ-78934804 · adalimumab vs SOR102

The roster

← all TNF-alpha drugs